Article & News

Gubba Group
How to sustain India’s vaccine success . . .

It would involve commitment to technological innovation, community empowerment, and collaborative action. Vaccines are one of the most effective tools in modern medicine and one

Gubba Group
Morepen to launch new fatty lever drug ‘Resmetirom’

Morepen Laboratories Ltd. has got clearance from Subject Expert Committee (‘SEC’) of Central Drugs Standard Control Organization (CDSCO) to conduct Bioequivalence (‘BE’) studies for Resmetirom